Compare MIST & FICO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIST | FICO |
|---|---|---|
| Founded | 2003 | 1956 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 163.2M | 41.2B |
| IPO Year | N/A | 1987 |
| Metric | MIST | FICO |
|---|---|---|
| Price | $2.41 | $1,843.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 13 |
| Target Price | $6.33 | ★ $2,050.69 |
| AVG Volume (30 Days) | ★ 5.3M | 171.1K |
| Earning Date | 11-12-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.78 |
| EPS | N/A | ★ 26.54 |
| Revenue | N/A | ★ $1,990,869,000.00 |
| Revenue This Year | N/A | $24.77 |
| Revenue Next Year | N/A | $17.55 |
| P/E Ratio | ★ N/A | $69.52 |
| Revenue Growth | N/A | ★ 15.91 |
| 52 Week Low | $0.63 | $1,300.00 |
| 52 Week High | $3.06 | $2,217.60 |
| Indicator | MIST | FICO |
|---|---|---|
| Relative Strength Index (RSI) | 46.58 | 62.26 |
| Support Level | $2.50 | $1,724.43 |
| Resistance Level | $2.73 | $1,813.55 |
| Average True Range (ATR) | 0.26 | 48.33 |
| MACD | -0.02 | 0.42 |
| Stochastic Oscillator | 48.62 | 88.47 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.